Since nuclear lectins were first characterized several years ago, six lectins have been isolated. Furthermore, the existence of nuclear glycoproteins containing N-linked complex-oligosaccharide chains or O-Iinked GlcNAc residues was evidenced. These latter are abundant in the nucleus and are well-studied so far. The presence of both glycoprotein and lectin in the cell nucleus led us to postulate that these two proteins could interact and play a role in some nuclear activities such as the modulation of transcription and/or nuclear cytoplasmic exchanges or by the disruption of protein-protein interactions. In such context, the recent data concerning the GlcNAc-binding activity of CBP70 argued this postulate. However, to study the possible role of a glycoprotein-lectin complex, it was critical to isolate the two partners. Because CBP70 was also a cytoplasmic protein, the lectin was isolated in both cytoplasmic and nuclear compartments in order to investigate the putative ligand in the two cellular compartments. The results obtained with cross-linking experiments on isolated and membranedepleted nuclei incubated with the CBP70 bearing an iodinatable, cleavable, photoreactive cross-linking agent (sulfosuccinimidyl 2-(/>-azidosalicylamido) ethyl-1,3'-dithiopropionate) and immunoprecipitation experiments with polyclonal antibodies raised against CBP70, revealed that both nuclear and cytoplasmic CBP70 have the same 82 kDa nuclear ligand which is absent in the cytoplasmic fraction. In addition, this ligand is glycosylated, containing GlcNAc residues, and, therefore, the complex between CBP70 and the 82 kDa polypeptide could be due to a glycoprotein-lectin interaction. These results raised the possibility that nuclear glycoprotein-lectin interaction could be involved in nuclear activities.
Introduction
Several years ago, the existence of nuclear lectins was demonstrated in different cell types (Hubert et al, 1985; Seve et al, 1985 Seve et al, , 1986 Moutsatsos et al, 1986; Olins et al, 1988) . Since then, six nuclear lectins have been characterized. CBP35 (CBP: carbohydrate-binding protein), recently named galectin-3 (Barondes et al, 1994) , and CBP14, recently named galectin-1 (Barondes et al, 1994) , were isolated from 3T3 fibre-blasts (Roff and Wang, 1983) and rat liver nuclei (Cuperlovic et al, 1995) , respectively. Both lectins were described as galactosebinding proteins, whereas CBP67, CBP33, and CBP70 recognize glucose (reviewed in Hubert and Seve, 1994) . The former two were isolated from rat liver nuclei (Schroder et al, 1992; Lauc et al, 1994) . The CBP70 was isolated from HL60 cell nuclei by affinity chromatography (Seve et al, 1993) and its localization was evidenced by immunofluorescence microscopy in HL60 cells by using antibodies raised against CBP70 (Hadj-Sahraoui et al, 1996) . Furthermore, recent data showed that CBP70 is also an N-acetylglucosamine (GlcNAc)-binding protein, like CBP22 which was coisolated with the former during GlcNAc affinity chromatography (Felin et al, 1994) . Nuclear lectins have been localized in nuclear areas enriched in ribonucleoprotein (RNP) complexes (Seve et al, 1986) . Both CBP67 and CBP35 were isolated from RNP complexes (Laing and Wang, 1988; Schroder et al, 1992) and the amino acid sequence deduced from the cDNA of CBP35 contains a portion that is homologous to certain regions of proteins of the heterogeneous nuclear RNP (hnRNP) complexes (Jia and Wang, 1988) . Although the role of nuclear lectins remains to be specified, some preliminary data suggested that CBP14 and CBP67 might be involved in the nucleocytoplasmic transport of mRNA (Schroder et al, 1992; Cuperlovic et al, 1995) , while CBP35 may participate in RNA splicing (Dagher et al, 1995) . Recently, CBP35 and CBP70 were coisolated during glucose affinity chromatography; these two lectins were completed during incubation via protein-protein interactions (Seve et al, 1993) . The CBP70-CBP35 linkage was disrupted upon lactosebinding to CBP35 probably because of a tridimensional modification of the CBP35 structure (Seve et al, 1993) . This result was corroborated in isolated and membrane-depleted nuclei (Seve et al, 1994) and suggests that glycoprotein-lectin interactions could modulate protein-protein interactions.
Furthermore, a line of evidence suggests the existence of nuclear glycoproteins containing N-linked complex-oligosaccharide chains (Reeves et al, 1981; Ferraro et al., 1991; Codogno et al., 1992) or O-linked GlcNAc residues (termed O-GlcNAc) (Holt and Hart, 1986; Haltiwanger et al, 1992) . These latter glycoproteins are abundant in the nucleus and some nuclear proteins which are involved in nuclear activities exhibit such glycosylation, for example Spl (Jackson and Tjian, 1988) , RNA polymerase H (Kelly et al., 1993) and nuclear pore proteins (nucleoporins) (Finlay et al., 1987) . It was further demonstrated that the binding of wheat germ agglutinin (WGA) to O-GlcNAc borne by nucleoporins and Spl inhibited active nucleocytoplasmic exchanges (Finlay et al, 1987) and the transcriptional activation function of Spl (Jackson and Tjian, 1988) , respectively. Thus, it could be hypothesized that some endogenous lectins could play the same role as WGA. The presence of both glycoproteins and lectins in the cell nucleus led to the hypothesis that these proteins might play their roles by interacting (Hubert et al., 1989) . Because glycoprotein-lectin interactions can be easily disrupted, this activity would be a simple way to modulate some nuclear activities. The recent data concerning the GlcNAc-binding activity of CBP70 strengthened this hypothesis (Felin et al., 1994) . However, before studying the role of glycoprotein-lectin interactions in the nuclei, it was essential to identify the endogenous nuclear ligand(s) for lectins.
In this article, for the first time, an 82 kDa endogenous nuclear ligand for CBP70 has been characterized by using cross-linking technique and this result was confirmed by coimmunoprecipitation of the 82 kDa polypeptide with CBP70. Although CBP70 was also purified from cytoplasmic extract, the 82 kDa ligand was not found in the cytoplasmic extract. Furthermore, we provided data strongly suggesting that the two partners are associated by a glycoprotein-lectin interaction.
Results

Control of the purity of cytoplasmic extracts
In previous studies, it was demonstrated that there was negligible contamination of the membrane-depleted nuclei by cytosolic proteins (Seve et al., 1993) . It was also important to ascertain that the cytoplasmic extract was not appreciably contaminated by nuclear proteins. HL60 cells were cultured in the presence of [ 14 C] leucine and the levels of radioactivity corresponding to 2 x 10 7 cells, and nuclei and cytoplasmic fractions derived from these 2 x 10 7 cells, were determined. Cytoplasmic extracts were then isolated from another 2 x 10 7 unlabeled cells suspended in the radioactive nuclei fraction. The results (Table I) indicated that there was negligible contamination (4%) of the cytoplasmic extract by nuclear protein.
Purification of cytoplasmic and nuclear CBP70
Purification of both nuclear and cytoplasmic CBP70 required two successive rounds of affinity chromatography (see Materials and methods). Briefly, cytoplasmic and total nuclear protein extracts were incubated on GlcNAc columns. The material bound to these columns was specifically eluted with 0.2 M GlcNAc (GlcNAc-eluted fractions). However, it was previously reported (Felin et al., 1994) that, under such experimental conditions, two lectins (CBP70 and CBP22) bound to the GlcNAc affinity column, which was incubated with total nuclear protein extract. Then, because CBP22 did not recognize glucose, the GlcNAc-eluted fraction was subjected to chromatography on a second-Glc affinity column. The same procedure was applied with protein eluted from the GlcNAc affinity column, which was incubated with cytoplasmic protein extract. The Glc-eluted fractions were subjected to SDS-12% PAGE and silver stained. Only one 70 kDa polypeptide was detected in both fractions ( Figure 1 , lanes a and b). After immunoblotting with antibodies raised against CBP70 of the same fractions, positive reactions were observed only on the 70 kDa band (Figure 1, lanes c and d) . These finding convinced us that uncontaminated preparations of nuclear and cytoplasmic CBP70 had been isolated.
Because CBP70 is present in the cytoplasm and the nucleus, we decided to determine whether the two forms of CBP70 recognized an identical ligand and whether the ligand was the same in the nucleus and in the cytoplasm. For these determinations, it was first necessary to isolate cytoplasmic and nuclear glycoproteins which could contain GlcNAc residues.
Characterization of nuclear and cytoplasmic glycoproteins that recognize WGA. CBP70 recognizes both GlcNAc and Glc, but with a higher affinity for the former (Felin et al., 1994) and until now, the only well-known glycoproteins in the nucleus contain OGlcNAc residues. In this context, WGA columns were incubated with the nuclear and cytoplasmic extracts, prepared from the same number of cells. Nuclear and cytoplasmic proteins eluted from the WGA columns were subjected to SDS-12% PAGE and silver stained. Several polypeptides were eluted in each case. In the eluted nuclear fraction 10 polypeptides, moreor-less, were visualized ( Figure 2 , lane a), whereas in the eluted cytoplasmic fraction the number of polypeptides cannot be determined because of the thick smear of polypeptides seen after silver staining (Figure 2, lane b) . However, the presence of an 82 kDa polypeptide can be noted in the eluted nuclear fraction that is not visible in the eluted cytoplasmic fraction. Some of these proteins might be putative ligand(s) for the CBP70.
Recognition of the putative ligand(s) by isolated nuclear and cytoplasmic CBP70 on WGA eluted proteins
To characterize the putative ligand(s) of cytoplasmic and nuclear CBP70, nuclear and cytoplasmic polypeptides eluted from WGA columns were subjected to SDS-PAGE and electroblotted. The Immobilon paper was incubated with isolated nuclear CBP70. Among the cytoplasmic glycoproteins, only Fig. 2 . Electrophorctic analysis of cytoplasmic and nuclear glycoproteins bound to WGA columns. The nuclear (a) or cytoplasmic (b) glycoproteins eluted from WGA columns by 0.2M GlcNAc were resolved by SDS-12% PAGE and silver stained.
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However, in such experiments, glycoproteins were solubilized and proteins complexes were disrupted. Thus, on Immobilon paper, CBP70 could recognize proteins, to which it did not bind in situ. No conclusion could be done about the nature of the interaction between CBP70 and the polypeptides electroblotted because it could not be ruled out that unspecific protein-protein or glycoprotein-lectin interactions could occur. Therefore, the cross-linking seemed a well-adapted technique for the characterization of the in situ putative nuclear ligand.
Identification of endogenous CBP70 ligands by cross-linking technique
The cross-Linking technique permits CBP70's ligand to be investigated directly on isolated nuclei. SASD has the following advantage: after iodination, Linkage of purified CBP70, incubation with isolated nuclei and finally cleavage of the crossone 75 kDa polypeptide was recognized ( Figure 3A , lane a), whiLe two polypeptides, 82 and 66 kDa, were recognized among the nuclear proteins ( Figure 3A , lane b). The control run with antibodies raised against CBP70 alone showed no positive labeling in either preparation of glycoproteins ( Figure 3A , lane c and d). This observation led us to conclude that the labeling seen in Figure 3A , lanes a and b, was not due to either the binding of the antibodies to endogenous CBP70 or to a crossreaction of the antibodies with polypeptides. Thus, nuclear CBP70 did not bind the same ligands in these cytoplasmic and nuclear extracts.
In parallel, the same study was performed with isolated cytoplasmic CBP70. Although cytoplasmic CBP70 recognized several polypeptides in the cytoplasmic glycoproteins fraction, no 82 kDa polypeptide was detected ( Figure 3B , lane a). Only an 82 kDa polypeptide was localized in the nuclear fraction ( Figure 3B , lane b). This finding showed that cytoplasmic CBP70, like nuclear CBP70, did not bind to the same ligands in cytoplasmic and nuclear glycoproteins preparations. As for nuclear CBP70, no positive labeling was observed when glycoprotein preparation was incubated with antibodies raised against CBP70 (data not shown). Surprisingly, among all GlcNAc-bearing glycoproteins, only a couple of proteins were recognized by both forms of CBP70. Because CBP70 is able to bind Glc (Seve et ai, 1993) and GlcNAc (Felin et al., 1994) , it could be presumed that CBP70 interacted with polysaccharides chains more complex than GlcNAc residues. This argues for a highly specific binding of CBP70 to its potential ligands. It should be mentioned that the same results were obtained when the experiments were performed in the presence of divalent cations (data not shown). This observation is not in agreement with affinity chromatography experiments in which it was necessary to add divalent cations to obtain the lectinbinding to the monosaccharide. This latter result might be explained by the fact that, on Immobilon paper, the saccharide moieties of the electroblotted ligand are the correct ones able to be recognized by the CBP70's carbohydrate recognition domain. Therefore, it appears that both nuclear and cytoplasmic CBP70 bind to the 82 kDa nuclear polypeptide but, in the cytoplasm, cytoplasmic CBP70 recognizes more ligands than nuclear CBP70 does. CBP70. The cytoplasmic (lanes Aa and Ac) and nuclear (lanes Ab and Ad) glycoproteins eluted from WGA columns were separated by a SDS-12% PAGE, electroblotted, incubated with isolated nuclear CBP70 (A), and probed with anti-CBP70 (lanes Aa and Ab) or with only anti-CBP70 (lanes Ac and Ad). In parallel, the cytoplasmic (lane Ba) and nuclear (lanes Bb) glycoproteins eluted from WGA columns were separated by a SDS-10% PAGE, electroblotted, incubated with isolated cytoplasmic CBP70 (B), and probed with anti-CBP70.The polypeptides were identified with the ECL reagent.
linker with (3-ME the labeled moiety remains attached to the ligand. The labeled ligand can then be visualized, free of CBP70, using autoradiography. The good conservation of nuclear CBP70 after its lS I-SASD labeling was confirmed by SDS-PAGE and electroblotting of an aliquot of the labeled fraction. No degradation of the nuclear protein was noted after immunoblotting and analysis with antibodies raised against CBP70 (Figure 4, lane a) . When the nuclei were incubated with free 125 I-SASD, no nonspecific binding of the agent to nuclear proteins was observed, only free 125 I-SASD was detected (Figure 4, lane b) . In comparison, when isolated nuclei were incubated with nuclear 12^I -SASD-CBP70, an 82 kDa polypeptide was characterized as shown in the autoradiogram (Figure 4 , lane c) while the 66 kDa polypeptide, detected on Immobilon paper ( Figure 3A, lane b) , was not visualized. This finding is probably due to the specific recognition of the ligand by the lectin. It can consequently be presumed that the 66 kDa polypeptide was not an in situ ligand for CBP70. The 66 kDa polypeptide is not due to a 82 kDa degradation because the experimental conditions for protein extraction were similar in both cross-linking and lectin blotting analysis. Note the presence of free 125 I-SASD at the migration front ( Figure 4 , lane c). The same results were obtained with cytoplasmic I23 I-SASD-CBP70 (data not shown).
To determine the nature of the interaction between the 82 kDa polypeptide and CBP70, the cross-Unking procedure was used as described above but, in this case, CBP70 and isolated nuclei were preincubated with 0.2 M GlcNAc; no labeling was detected subsequently (Figure 4, lane d) . The competition observed with GlcNAc, but not with 0.2M Fuc or 0.2M Gal (data not shown), strongly argues for a glycoprotein-lectin interaction between CBP70 and the 82 kDa polypeptide.
Futhermore, the nuclear polypeptides eluted from a WGA column were resolved by SDS-PAGE, the 82 kDa polypeptide, which was detected after silver stained (Figure 2 , lane a) and recognized by isolated nuclear CBP70 after electroblotting ( Figure 3A , lane b), was solubilized from the gel, resubjected to SDS-PAGE and then electroblotted. After the immunoblotting analysis with succinylated-biotinylated-WGA (sWGA), which is known to recognize only GlcNAc moieties, a 82 kDa polypeptide was detected (Figure 4 , lane e). Obviously, it could not be ruled out that there was two polypeptides which comi- grated at 82 kDa, one that reacted with CBP70 and another that reacted with sWGA. Nevertheless, this result is in agreement with data obtained by cross-linking experiment and, then, strongly suggest that the putative ligand for CBP70 is a glycoprotein containing at least GlcNAc residues, which further support a glycoprotein-lectin interaction.
Identification of endogenous lectin ligands by coimmunoprecipitation with CBP70
In order to confirm the interaction between CBP70 and the 82 kDa polypeptide in the nuclear and the absence of the 82 kDa polypeptide in the cytoplasmic extract, the nuclear and cytoplasmic proteins coimmunoprecipitated with CBP70 were analyzed and detected by autoradiography: the immune complexes brought down by protein A-agarose were washed, separated by SDS-PAGE and autoradiographed. As shown in Figure 5 , among polypeptides coimmunoprecipitated with CBP70 from nuclear extract is an 82 kDa polypeptide (lane a), which is absent in the cytoplasmic extract (lane b). This result corroborated the identification of a 82 kDa CBP70 ligand, specifically localized in the nucleus. As it was observed with cross-linking experiments, the 66 kDa polypeptide was not coimmunoprecipitated from the nuclear extract ( Figure 5, lane a) . This data argued for a nonspecific interaction, on Immobilon paper, between CBP70 and this polypeptide. In both cases, no polypeptides were detected when experiments were performed with the preimmune serum ( Figure 5, lanes c and d) .
Note that CBP35, which was previously coisolated with CBP70 during glucose affinity chromatography (S6ve et al., 1993) , was not coimmunoprecipitated with CBP70 under such conditions, probably due to a quantity issue. Nevertheless, CBP35 was detected when immunoprecipitation was performed from total cellular extract (data not shown).
Discussion
The demonstration of the combined presence of both lectins and glycoproteins in the cell nucleus several years ago led to the hypothesis of possible interactions between these proteins which might be responsible for nuclear activities (Hubert et al., 1989) . However, at present, such interactions remained theoretical and, to confirm them, the characterization of a glycosylated nuclear lectin ligand was essential.
It was previously shown that CBP70 recognizes both GlcNAc and Glc with a higher affinity for the former (Felin et al., 1994) and, in addition, until now, the only well-known glycoproteins in the nucleus contained O-GlcNAc residues. Consequently, to identify the putative ligand of nuclear CBP70, glycoproteins bearing GlcNAc residues were isolated from HL60 cells. However, to determine whether putative nuclear ligand(s) could also be present in the cytoplasm, studies were performed using preparations of nuclear and cytoplasmic proteins. Futhermore, because CBP70 is also present in the cytoplasm as demonstrated by using both affinity chromatography and immunofluorescence microscopy techniques (HadjSahraoui et al., 1996) , it appeared important to determine whether the CBP70 isolated from the cytoplasm (cytoplasmic CBP70) and that isolated from the nucleus (nuclear CBP70) bound to the same ligand(s).
For such studies, CBP70 was purified from nuclear and cytoplasmic preparations obtained without any contamination. When Glc or GlcNAc affinity chromatography were performed with the nuclear extract, two polypeptides, CBP70/CBP35 (Seve et al., 1993) and CBF70/CBP22 (Felin et al, 1994) , were isolated respectively. The combination of two successive affinity chromatography (GlcNAc and Glc) allowed us to obtain purified nuclear CBP70. The cytoplasmic CBP70 was purified by applying the same procedure. Both CBP70 interacted with different ligands among the cytoplasmic and nuclear WGA-eluted polypeptides. Two ligands were recognized by the nuclear CBP70 in the nucleus (82 and 66 kDa) and only one (75 kDa) in the cytoplasm. Under the same conditions, only one ligand (82 kDa) was recognized by cytoplasmic CBP70 in the nucleus, while several putative ligands were identified among the cytoplasmic glycoproteins. These results showed that nuclear and cytoplasmic CBP70 recognized ligands in both the cytoplasm and the nucleus and, more interestingly, these ligands were different in these two compartments. However, it was clear that cytoplasmic and nuclear CBP70 shared a common 82 kDa nuclear ligand. It remains to be clarified why cytoplasmic CBP70 recognized more ligands among the cytoplasmic glycoproteins than the nuclear CBP70 did. It must be recalled that glycosylation takes place in the cytoplasm and several glycoproteins could contain residues recognizable by cytoplasmic CBP70. A major possibility capable of explaining all these differences, could be that, since the two CBP70 have similar GlcNAc-binding sites and the same molecular mass and are labeled by the same antibodies, the two lectins could be similar but not totally identical. Preliminary data obtained by our group suggest that different posttranslational modifications might exist between the nuclear and the cytoplasmic forms of CBP70 (unpublished results). Although these findings raise interesting possibilities, our primary objective in this study was the identification of a nuclear ligand and indeed we were able to characterize a common potential 82 kDa nuclear ligand for nuclear and cytoplasmic CBP70.
However, it could not be ruled out that unspecific interactions could occur between CBP70 and solubilized glycoproteins during the lectin blotting technique. Because the crosslinking method allowed the direct investigation of CBP70 ligands on isolated nuclei in a complex mixture of proteins, that is, in its physiological environment, it appeared to be a well adapted technique. Thus, a 82 kDa ligand was identified but the 66 kDa nuclear polypeptide, recognized by the nuclear CBP70 after immunoblotting analysis, did not react with CBP70 in isolated and membrane-depleted nuclei. It should be note that among the multitude of glycoproteins present in the cell nucleus, especially glycoproteins bearing GlcNAc residues, only one was recognized by CBP70. This finding probably reflects the specific recognition of the lectin by its ligand. Futhermore, the 82 kDa polypeptide, but not the 66 kDa polypeptide, was coimmunoprecipitated with CBP70 in nuclear extract and was not detected in cytoplasmic extract. This result corroborated the identification of a 82 kDa nuclear CBP70 ligand. Surprisingly, no CBP35 was recognized by the 125 I-SASD-CBP70. However, a protein-protein interaction in HL60 cells nuclei between CBP70 and CBP35 was reported (Seve et al., 1993) and CBP35 was coimmunoprecipitated with CBP70 in total cellular extract. This observation could be explained by the following points: (1) the CBP70 affinity is higher for its 82 kDa ligand than for CBP35 and, in this case, it could be hypothesized as previously reported (Felin et al., 1994) that the binding of the 82 kDa ligand into the CBP70 CRD prevent the protein-protein interaction between CBP70 and CBP35; (2) the cross-linker bound CBP70 on its proteinprotein interaction domain.
Next, the nature of the interaction between the 82 kDa polypeptide and CBP70 was investigated. Although it has previously been reported that a monosaccharide such as lactose could modulate the protein-protein interaction between two lectins (Seve et al., 1993) , it remains that (1) CBP70 is a GlcNAc-binding protein; (2) CBP70 did not bind to the 82 kDa polypeptide, when competition was performed with GlcNAc during the cross-Unking experiment; (3) the 82 kDa polypeptide bore GlcNAc residues, as revealed by biotinylatedsuccinylated WGA, data that strongly argue for a high specificity glycoprotein-lectin interaction between CBP70 and the 82 kDa polypeptide.
For the first time, a glycosylated ligand for a lectin has been characterized in the nucleus. The second important observation was that this ligand was not present in the cytoplasm, while some other putative cytoplasmic ligands do exist. Furthermore, because CBP70 was found in both the nucleus and the cytoplasm, it could be concluded, as previously described for CBP35, that this lectin is a plurifunctional protein.
These new results are in agreement with the postulate proposed several years ago by our group concerning the possible involvement of glycoproteins and lectins in nuclear activities (Hubert et al., 1989) . At present, the 82 kDa glycoprotein appears to be present only in the nucleus. This finding allows us to postulate that it would be possible for this lectin and its ligand to interact in this compartment where both proteins are present Consequently, because a nuclear lectin and its ligand have been obtained for the first time, it can reasonably be thought that the study of the roles of these proteins will be facilitated, and experiments are now in progress to elucidate the function of this nuclear complex in nuclear physiology. ghitamine, 50 IU/ml of penicillin, and 50 mg/ml of streptomycin. Cells were incubated at 37°C in a humidified 5% CO 2 atmosphere and maintained at a density of 2 x 10 3 to 1 x 10 6 cells/ml by resuspending them in fresh culture medium every 3 days. When required, 2 x 10 7 cells grown in RPMI 1640, were transferred in leucine-free RPMI medium supplemented as described above. Then 25 u.g/ml of unlabeled leucine or 25 u.g/ml of [ M C] leucine (NEN DuPont) were added to the culture medium (0.18 x 10~3 GBq/ml final). Cells were allowed to grow for 3 h in the presence of radiolabeled leucine. For immunoprecipitation, 4 x 10 7 HL60 cells were grown in RPMI 1640 medium and 50 u.Ci of [
Materials and methods
Cell culture
35 S] methionine (293 MBq/ml) (NEN DuPont) were added per ml of medium. Cells were allowed to grow overnight in the presence of radiolabeled methionine. Cells were used between passages 15 and 40.
Cell fractionation and protein extraction
Very clean membrane-depleted nuclei were isolated from HL60 cells according to a previously reported method (Facy et al., 1990) . Briefly, exponentially growing HL60 cells (1 x 10 9 cells) were washed twice in 10 mM Tris-HCl (pH 7.5) containing 20 mM KC1, 2 mM CaCl 2 , 2 mM MgCl 2 , and 0.2 mM spermidine (TKCM buffer), and collected by low-speed centrifugation (800 x g for 10 min). The cell pellets were resuspended in 20 ml of TKCM buffer containing 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml each of antipain, leupeptin, pepstarin A, and chymostatin; 0.17 IU/ml of aprotinin and 20 mM benzamidine as protease inhibitors (Sigma, Saint Louis, MO). Triton X-100 was added at a final concentration of 0.5%. Cells were homogenized and membrane-depleted nuclei were pelleted by centrifugation at 1000 x g for 10 min. The supernatant was centrifuged at 100,000 x g for 1 h at 4°C using a Beckman rotor type 55.2 Ti. The supernatant containing cytoplasmic proteins was then dialyzed against Ca 2+ and Mg 2 * free phosphate-buffered saline (PBS~) at 4°C overnight. This dialyzed supernatant will be named cytoplasmic extract throughout the text. Nuclear proteins were extracted from membranedepleted nuclei with NaCl adjusted to 2 M (final concentration) in TKCM buffer for 1 h at room temperature. Excess NaCl was removed by overnight dialysis against PBS~ at 4°C, and the proteins were concentrated on a Centricon 10 filters (Grace and Co., Danvers, MA). All steps of the isolation procedure were carried out at 4°C.
Control of the purity of cytoplasmic extracts
Membrane-depleted nuclei were isolated from 2 x 10 7 cells grown in the presence of [ 14 C] leucine. The nuclear pellet and the supernatant (5 ml) were separated and the radioactivity of each fraction was counted. Unlabeled cells (2 x 10 7 ) were then resuspended in 5 ml of radiolabeled nuclei fraction. The cells were then homogenized in the presence of Triton X-100. Membranedepleted nuclei were pelleted by centrirugation at 1000 x g for 10 min. The supernatant, containing cytoplasmic proteins, was centrifuged at 100,000 x g for 1 h at 4°C, and the radioactivity of the cytoplasmic extract was counted.
Affinity-chromatography procedures
N-Acetyl-p-D-glucosamine phenylisothiocyanate (GlcNAc-ip-NCS) and a-r> glucopyranosylisothiocyanate (Glc-<p-NCS) (Sigma Chemical Co., St. Louis, MO) were immobilized on acetone-dehydrated Trisacryl GF 2000 M (IBF, Villeneuve-La-Garenne, France). The nuclear protein solution or the cytoplasmic extract was adjusted to 0.7 mM CaCl 2 and 0.5 mM MgCl 2 (PBS*), and affinity chromatography was performed as previously described (Save et al., 1993) . CBP70 has previously been identified in HL60 cell nucleaT extracts subjected to Glc (Save et al, 1993) or GlcNAc (Felin et al., 1994) affinity chromatography. More recently, our group has detected CBP70 in cytoplasmic extracts (Hadj-Sahraoui et al., 1996) using GlcNAc affinity chromatography columns and immunofluorescence microscopy. However, under such experimental conditions, CBP70 was not isolated to homogeneity. To obtain purified nuclear or cytoplasmic CBP70, the proteins eluted from GlcNAc columns with 0.2 M GlcNAc, were dialyzed against PBS* overnight at 4°C and then incubated with Glc columns and eluted with 0.2 M Glc. The eluted fraction was concentrated on Centricon-10 filters. The protein concentration was determined using the Micro BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). Affinity chromatography was also performed with WGA insolubilized on Sepharose 6 Mbyte (Sigma). The nuclear or cytoplasmic extract, obtained from the same number of cells (1 x 10 9 ), was incubated with 1 ml of immobilized WGA overnight at 4°C under batch conditions. After packing in columns, the same procedure as that described above was applied. The proteins specifically retained on WGA were eluted with 0.2 M GlcNAc and concentrated on Centricon-10 filters.
Electrophoresis analysis
The polypeptides were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12% acrylamide mini-slab running gels under denaturing conditions, according to Laemmli's procedure (Laemli, 1970) . The polypeptide bands were visualized by silver staining. Molecular mass markers were from Bio-Rad.
Protein elutionfrom SDS-PAGE
Proteins eluted from the WGA column were resolved by SDS-PAGE on 12% acrylamide running gels under denaturing conditions and then eluted from the gels as previously described (Felin et al., 1994) .
Immunoblotting or lectin blotting analysis
Polypeptides, resolved by SDS-PAGE on 12% or 10% acrylamide mini-slab running gels, were transferred electrophoretically onto Immobilon-P paper (Millipore, Bedford, MA) (60 V at room temperature for 1 h) in 10 mM (cyclohexylamino)-l-propane sulfonic acid, pH 10.7 (Caps buffer). The Immobilon paper was incubated overnight in saturating TBS buffer (20 mM Tris-HCl (pH 7.4), 0.5 M NaCl) containing 5% milk powder. The paper was then treated as follows. (1) It was washed three times in TBS containing 0.5% Tween 20 (TBS-T) and incubated for 3 h with rabbit antiserum raised against CBP70 (anti-CBP70), obtained as previously described (Sive et al., 1994) and diluted 1:1000 in TBS-T. After incubation in the presence of antibodies, the paper was washed three times in TBS-T, incubated for 1 h at 4°C with alkaline phosphatase-conjugated goat anti-rabbit IgG (Sigma) at a dilution of 1:8000, then washed three times in TBS-T and finally in Tris-buffer (0.1 M Tris-HCl (pH 9.5), 100 mM NaCl and 5 mM MgCy before staining with the 5-bromo 4-chloro-3-indolyl phosphate (BCIP) and nitroblue tetrazolium (NBT) (Sigma) substrate. Controls were run to assure the lack of nonspecific binding of alkaline phosphatase-conjugated goat anti-rabbit IgG and the absence of endogenous alkaline phosphatase. (2) It was washed three times in TBS-T and incubated for 3 h with 31.5 u,g of isolated nuclear or cytoplasmic CBP70 in 1 ml of TBS-T, then with anti-CBP70, diluted 1:1000 in TBS-T. After incubation in the presence of antibodies, the paper was washed three times in TBS-T, incubated for 1 h at 4°C with peroxidase-conjugated goat anti-rabbit IgG (Sigma) at a dilution of 1:1000, and then washed three times in TBS-T before staining with ECL Western blotting detection system (Amersham). In order to verify whether the same labeling was obtained in the presence of divalent cations, the same study was performed with TBS-T containing 1 mM CaCl 2 and MgCl 2 (TBS-T+). Control was run to assure the lack of nonspecific binding of anti-CBF70. (3) It was washed three times in TBS-T and incubated for 2 h with biotinylated-succinylated-WGA (EY Laboratories, Inc., San Mateo, CA) diluted 1:1000 in TBS-T+. The paper was then washed three times in TBS-T+, incubated for 1 h with peroxidase-streptavidin-labeled (Sigma) at a dilution of 1:1000 in TBS-T+, then washed three times in TBS-T+ and finally in 50 mM Tris buffer before staining with the 4-chloro 1-naphthol substrate.
Cross-linking
SASD (3 mg) (sulfosucciniraidyl 2-(p-azidosalicylamido)ethyl-l,3'-dithiopropionate) (Pierce) were dissolved in 50 u.1 of dimethyl sulfoxide in a glass tube. This stock SASD solution was diluted 1:200 in 0.1 M sodium phosphate buffer (pH 7.4 ) and was iodinated using Iodogen (Pierce) as previously described (Felin et al., 1994) . Briefly, polypropylene test tubes (17 x 100 mm) were coated with 300 mg iodogen dissolved in 300 ml of chloroform, and the solvent was eliminated undeT a stream of dry nitrogen. To each Iodogen-coated tube was added 40 u-Ci of Na '"I (Dupont NEN S.A, Les Ulis, France), 18.5 nmol of potassium iodide in 10 u.1 of 0.1 M sodium phosphate (pH 7.4), and 100 u.1 of the diluted SASD solution. After incubation at room temperature for 30 s, the reaction was terminated by removal of the solution from the reaction tube. Then, 31.5 (xg of purified cytoplasmic or nuclear CBP70 in 1 ml of 0.1 M sodium borate buffer (pH 8.4) was added to the solution. Under alkaline conditions CBP70 displaced the sulfosucciiumidyl moiety, forming l25 I-SASD-CBP70. After incubation at room temperature for 30 min, the unreacted SASD was removed by applying the reaction mixture to a 2 ml Excellulose GF-5 desalting column (Pierce) which had been equilibrated with 10 column volumes of TKCM buffer. Fractions of 1 ml were collected by ehition with TKCM. The radioactivity was counted (LKB Wallac, 1275 Minigamma counter, LKB Instruments S A, Orsay, France), and the first radioactive fraction eluted was used for the next step (protein-SASD solution). Membrane-depleted nuclei were isolated from 2x10* cells as described above except that the last wash was performed with 0.1 % Teleostean gelatin (Sigma) in TKCM buffer. The isolated nuclei were incubated with the protein-SASD solution for 2 h at 4°C, and then nuclei were collected by low-speed centrifugation (800 x g for 10 min). The pelleted nuclei were washed twice in 1 ml of TKCM buffer. The nuclei were irradiated with long-wave UV light (460 u.W/ cm 2 ) for 10 min at room temperature to initiate photolysis of the azide bond and covalent linkage of 125 I-SASD-CBP70 to the nuclear ligand, and then flashed with bright light for 1-3 s (three camera flashes of 1 s each work well). All these steps were carried out under dim (40 W) red light in a darkroom. Nuclear proteins were extracted as described above, then the proteins were concentrated on Centricon-10 filters and the radioactivity was measured in a gamma counter. Polypeptides were resolved by SDS-PAGE on 12% acrylamide mini-slab running gels in the presence of B-mercaptoethanol (B-M E), subjected to autoradiography and identified-Controls were run to assure the lack of nonspecific binding of 125 I"SASD alone and the good conservation of CBP70 after the labeling procedure. In parallel, the nuclei (2 x 10 s ) or 31.5 u.g/ml of purified nuclear or cytoplasmic CBP70 were preincubated with 0.2 M GlcNAc or 0.2 M fucose (Fuc) or 0.2 M Gal for 3 h. The nuclear proteins were then treated as described above.
Immuiwprecipitation
Following metabolic labeling with [ 33 S] methionine, cytoplasmic and nuclear extracts were isolated as described above. After dialysis against PBS" overnight, 0.5% Triton X-100, 0.25% SAB, 0.5 mM MgCl 2 , and 0.7 mM CaCl 2 were added to the cytoplasmic and nuclear extracts. Then, extracts were precleared by incubation 1 h at 4°C with 200 uJ of a 50% (w/v) suspension of protein A-agarose (Kem En Tec, Denmark) in immunoprecipitation buffer (0.5% Triton X-100, 0.25% SAB, 1 mM PMSF in PBS' P ). Immunoprecipitation was initiated by adding 10 u.g of anti-CBP70 antibodies to the precleared supernatant for 2 h at 4°C, followed by 100 \iX of a 50% suspension of protein A-agarose. The reaction mixture was incubated 1 h at 4°C, after which the beads were washed five times with immunoprecipitation wash buffer (1% Tnton X-100, 0.5% SAB, 1 mM PMSF in PBS + ), and then washed two times with PBS + . The washed immunoprecipitates were separated by SDS-10% PAGE under denaturating conditions as previously described and autoradiographed. Control immunoprecipitates used prcimmune serum in place of anti-CBP70 antibodies.
Molecular masses of radiolabeled polypeptides were calculated by coelectrophoresing [
14 C] methylated protein standards (97,400-46,000-30,000, Amersham SA Les Ulis, France).
